tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Eisai Co (ESALY)
OTHER OTC:ESALY
ESALY
Eisai Co
Stock Analysis
News & Insights
Options
Chart
Dividends
Ownership
Financials
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Holding ESALY?
Track your performance easily
Link Broker

Eisai Co (ESALY) Stock News & Sentiment

0 Followers
Eisai, Biogen say lecanemab received Priority Review status in Japan
Premium
The Fly
Eisai, Biogen say lecanemab received Priority Review status in Japan
2y ago
BIIB
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
Premium
The Fly
Eisai, Biogen: EMA accepts MAA for lecanemab for early Alzheimer’s disease
2y ago
BIIB
Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII
Premium
The Fly
Catalyst Pharmaceuticals completes acquisition of U.S. rights to FYCOMPA CII
2y ago
CPRX
Donanemab CRL a ‘positive headline’ for Biogen’s Leqembi, says William Blair
Premium
The Fly
Donanemab CRL a ‘positive headline’ for Biogen’s Leqembi, says William Blair
2y ago
LLY
BIIB
Eisai submits marketing authorization application for lecanemab in Japan
Premium
The Fly
Eisai submits marketing authorization application for lecanemab in Japan
2y ago
BIIB
Eisai submits MAA for lecanemab to EMA
Premium
The Fly
Eisai submits MAA for lecanemab to EMA
2y ago
BIIB
Eisai submits Leqembi sBLA to FDA
Premium
The Fly
Eisai submits Leqembi sBLA to FDA
2y ago
ESALY
More ESALY News >

ESALY News on the Web

Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
CNBC
Neutral
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
CNBC
Bearish
Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
CNBC
Neutral
UPDATE 1-Japan gives priority review status to Alzheimer's drug developed by Eisai, Biogen
Yahoo Finance
Neutral
Biogen & Eisai's Lecanemab Secures EMA's MAA Acceptance
Yahoo Finance
Neutral
UPDATE 1-EU regulator accepts for review Alzheimer's treatment from Eisai-Biogen
Yahoo Finance
Neutral
Catalyst Down on TEVA's FDA Filing for Firdapse Generic
Yahoo Finance
Neutral
Catalyst (CPRX) Down on TEVA's FDA Filing for Firdapse Generic
Zacks
Neutral

News Score - Last 7 Days

Neutral
ESALY
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESALY’s Media Buzz Sentiment?
Currently, no data Available
What is ESALY’s weekly average amount of articles?
Currently, no data Available
What is ESALY’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
HOOKHookipa Pharma
PRVBProvention Bio
BLCMBellicum Pharmaceuticals
VSTMVerastem
ARDSAridis Pharmaceuticals
Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis
Subscribe NowSee Plans & Pricing